Bowen, J. http://orcid.org/0000-0003-0876-0031
,
Al-Dasooqi, N.
Bossi, P.
Wardill, H.
Van Sebille, Y.
Al-Azri, A.
Bateman, E.
Correa, M. E.
Raber-Durlacher, J.
Kandwal, A.
Mayo, B.
Nair, R. G.
Stringer, A.
ten Bohmer, K.
Thorpe, D.
Lalla, R. V.
Sonis, S.
Cheng, K.
Elad, S.
Article History
Received: 31 January 2019
Accepted: 22 May 2019
First Online: 8 July 2019
Compliance with ethical standards
:
: Authors that report no conflict of interest: JB, NA, HW, YVS, AA, JRD, EB, MEC, JRD, AK, BM, RN, AS, KTB, DT, KC, SE.PB has served an advisory role for AstraZeneca, Helsinn, and Kyowa Kyrin and received grants from Merck, Kyowa Kyrin, and Roche. RVL has served as a consultant for Colgate Oral Pharmaceuticals, Galera Therapeutics, Ingalfarma SA, Monopar Therapeutics, Mundipharma, and Sucampo Pharma; has received research support to his institution from Galera Therapeutics, Novartis, Oragenics, and Sucampo Pharma, and has received stock in Logic Biosciences. SS is an employee at Biomodels LLC and a partner at Primary Endpoint Solutions.